Tel. +39 010.51862.1

To access the complete product information, login

Muciclar

SKU: -2762 Category:

Active principle

Ambroxolo

Therapeutic class

Secretolytic therapy in acute and chronic bronchopulmonary diseases associated with abnormal mucus secretion and impaired mucus transport.

Package

 

  • 15 mg/2 ml solution for inhalation – 30 units
  • 30 mg granulate oral solution – 30 sachets
  • 0,3% Syrup – 200 ml bottle
  • 75 mg slow-release capsules – 20 caps

Reimbursement class

SOP

ATC code

R05CB06

Description
Additional information

Active principle

Ambroxolo

Therapeutic class

Secretolytic therapy in acute and chronic bronchopulmonary diseases associated with abnormal mucus secretion and impaired mucus transport.

Package

 

  • 15 mg/2 ml solution for inhalation – 30 units
  • 30 mg granulate oral solution – 30 sachets
  • 0,3% Syrup – 200 ml bottle
  • 75 mg slow-release capsules – 20 caps

Reimbursement class

SOP

ATC code

R05CB06